Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

Tetsuya Niihori1, Yoko Aoki, Yoko Narumi

  • 1Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan.

Nature Genetics
|February 14, 2006
PubMed

Insights

Cardio-facio-cutaneous (CFC) syndrome shares features with Noonan and Costello syndromes. Genetic analysis revealed KRAS and BRAF mutations in CFC patients, implicating the RAS-RAF-ERK pathway in these related disorders.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • Cardio-facio-cutaneous (CFC) syndrome presents with characteristic facial features, cardiac anomalies, and intellectual disability.
  • CFC syndrome exhibits phenotypic overlap with Noonan syndrome and Costello syndrome.
  • Noonan and Costello syndromes are linked to mutations in PTPN11 and HRAS genes, respectively.

Purpose of the Study:

  • To investigate the genetic underpinnings of Cardio-facio-cutaneous (CFC) syndrome.
  • To explore the molecular relationship between CFC, Noonan, and Costello syndromes.

Main Methods:

  • Genetic analysis of 43 individuals diagnosed with CFC syndrome.
  • Identification and sequencing of mutations in key genes within the RAS-RAF-ERK pathway.

Main Results:

  • Two heterozygous KRAS mutations were identified in three individuals with CFC syndrome.
  • Eight BRAF mutations were found in 16 individuals with CFC syndrome.
  • These findings suggest a significant role for KRAS and BRAF mutations in CFC syndrome.

Conclusions:

  • Dysregulation of the RAS-RAF-ERK signaling pathway is a common molecular mechanism underlying CFC, Noonan, and Costello syndromes.
  • Identifying mutations in KRAS and BRAF provides crucial insights into the pathogenesis of CFC syndrome.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...